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Dimethylisosorbide	 (DMI)	 as	 a	 bio-derived	 solvent	 for	 Pd-catalysed	
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Abstract Palladium-catalyzed bond forming reactions, such as the Suzuki-
Miyaura and Mizoroki-Heck reactions, are some of the most broadly utilized 
reactions within the chemical industry. These reactions frequently employ 
hazardous solvents; however, to adhere to increasing sustainability pressures 
and restrictions regarding the use of such solvents, alternatives are highly 
sought after. Here we demonstrate the utility of dimethyl isosorbide (DMI) as 
a bio-derived solvent in several benchmark Pd-catalysed reactions: Suzuki–
Miyaura (13 examples, 62–100% yield), Mizoroki–Heck (13 examples, 47–
91% yield), and Sonogashira (12 examples, 65–98% yield).	
Key words Cross-coupling; green chemistry; palladium; solvents 	Continuing	endeavours	by	leading	industrial	companies	and	academic	groups	place	solvent	replacement	strategies	at	the	forefront	 of	 green	 chemistry	 initiatives.	 The	 search	 for	alternative	solvents	 is,	 in	part,	driven	by	health,	 safety,	and	environmental	 issues	 regarding	 the	 use	 of	 solvents	 of	concern.1-6	 For	 example,	 dipolar	 aprotic	 solvents	 such	 as	DMF	 and	 NMP	 are	 teratogenic,	 whilst	 1,4-dioxane	 is	carcinogenic.	 As	 such,	 these	 solvents,	 in	 addition	 to	 many	others,	have	fallen	under	strict	regulation.	Subsequently,	 solvent	 selection	 has	 become	 a	 key	 focus	within	 the	 pharmaceutical	 sector,	 with	 many	 groups	developing	 tools	 and	 methods	 to	 rank	 existing	 solvents	based	 on	 risks	 posed	 or	 favourable	 physical	 properties.7-13	These	 guides	 allow	 the	 end	 user	 to	 assess	 and	 adjust	 their	reaction	manifold	by	aiding	in	the	identification	of	a	suitable	solvent	 alternative	which	adheres	 to	best	practice	 in	 safety	guidelines	 and	 regulation.14,15	 Despite	 these	 efforts,	 direct	substitution	 can	 be	 challenging	 particularly	 with	 dipolar	aprotics.	 The	 unique	 physical	 properties	 of	 these	 solvents	
make	them	indispensable	to	practitioners	and,	as	such,	novel	alternatives	are	required.		The	 use	 of	 biomass	 feedstocks	 in	 the	 development	 of	 new	chemical	products	is	a	growing	area	within	Green	Chemistry,	aiming	 to	 minimise	 dependence	 on	 petroleum-based	chemicals	and	overall	environmental	impact	of	the	chemical	industries.16-23	However	the	uptake	of	neoteric	solvents	can	often	 be	 slow	 when	 application	 is	 underexplored.	 Some	recent	examples	of	the	applications	of	new	solvents	 include	studies	on	γ-valerolactone	and	CyreneTM.24-34		Derived	 from	 glucose	 via	 the	 platform	 molecule	 sorbitol,	(Figure	1),	dimethyl	isosorbide	(DMI)	has	found	application	in	 the	 formulation	 of	 cosmetics	 and	 pharmaceuticals.35-38	Despite	 displaying	 similar	 Hansen	 solubility	 parameters	(HSP)39	 to	 traditional	 dipolar	 aprotic	 solvents	 and	 some	promising	 investigations	 into	 the	 use	 of	 DMI	within	 amide	bond	 formation,40,41	 its	 broader	 application	 within	 organic	synthesis,	 in	 particular	 transition	 metal	 catalysis,	 is	underdeveloped.	Herein	we	report	the	use	of	DMI	as	a	viable	alternative	 to	 solvents	 of	 concern	 within	 key	 C–C	 bond	forming	 reactions	 widely	 used	 in	 synthetic	 organic	chemistry.	
 
Figure 1 Sorbitol as the platform molecule in the synthesis of DMI. Palladium-catalysed	 bond	 forming	 reactions	 are	 an	important	 tool	 within	 the	 pharmaceutical	 arena	 and	 are	often	key	steps	in	the	syntheses	of	modern	drug	compounds	
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(Figure	 2).42-46	 Reactions	 such	 as	 the	 Suzuki-Miyaura	(SM)47,48	 and	 Mizoroki-Heck	 (MH),49	 allow	 for	 late	 stage	derivatisation	 and	 divergent	 syntheses	 from	 readily	available	materials,	 and	 the	Sonogashira	 reaction	 facilitates	the	installation	of	an	internal	alkyne,50	a	versatile	functional	group	 and	 important	 intermediate	 for	 subsequent	elaboration.	 The	 robustness	 of	 these	 transformations	 often	relies	on	the	use	of	solvents	of	concern.	THF	and	1,4-dioxane	are	common	solvents	used	for	the	SM	reaction	whilst	DMF	is	the	traditional	medium	within	the	Sonogashira	reaction.51	
 
Figure 2 The most common cross-coupling reactions in pharma. Our	aim	was	to	assess	whether	DMI	was	viable	as	a	medium	for	these	most	common	cross-coupling	processes.	We	began	our	investigations	by	assessing	the	utility	of	DMI	within	the	SM	 cross-coupling	 of	 phenylboronic	 acid	 and	 p-bromotoluene	(Table	1).	Using	conditions	established	within	our	 laboratories,52	 an	 initial	 temperature	 screen	demonstrated	 that	 the	 coupling	 could	 be	 carried	 out	 with	high	conversions	at	40	°C	in	1	h	(Entry	2).	Additionally,	the	catalyst	loading	could	be	reduced	to	as	low	as	1	mol%	before	any	significant	erosion	of	conversion	was	observed.		
Table 1 Reaction optimisation of Suzuki–Miyaura conditions.a 
 
Entry Reaction condit ions 
Conversion 
(%)b 
1 30 °C, Pd(dppf)Cl2 (4 mol%) 72 
2 40 °C, Pd(dppf)Cl2 (4 mol%) 93 
3 60 °C, Pd(dppf)Cl2 (4 mol%) 100 
4 40 °C, Pd(dppf)Cl2 (2 mol%) 92 
5 40 °C, Pd(dppf)Cl2 (1 mol%) 92 
6 40 °C, Pd(dppf)Cl2 (0.5 mol%) 80
 
a4-Bromotoluene (1 equiv., 0.25 mmol), phenylboronic acid (1 equiv., 0.25 
mmol), K3PO4 (3 equiv., 0.75 mmol), H2O (5 equiv., 1.25 mmol), DMI (1 mL, 
0.25 M). b NMR conversion given as an average over 2 reactions.  	Whilst	 we	 were	 able	 to	 synthesise	 a	 small	 range	 of	substrates	 (Scheme	 1,	 3f,	 3j,	 3m)	 using	 2	 mol%	 catalyst	loading	at	60	°C,	to	accommodate	a	broader	efficiency	within	the	 substrate	 classes,	 we	 found	 it	 was	 necessary	 to	 use	 a	slightly	 higher	 catalyst	 loading	 of	 4	 mol%.	 With	 these	
conditions	(Table	1,	Entry	3),	we	were	able	to	carry	out	the	coupling	 of	 a	 range	 of	 aromatic	 (3b,	3l)	and	 vinyl	 (3g,	3k)	boronic	 acids	 and	pinacol	 esters	 in	high	yield.	Additionally,	as	 is	 standard	 within	 the	 SM	 cross-coupling,	 electrophile	variation	was	well	tolerated	(3c,	3e,	3m).	Aromatics	bearing	electron-withdrawing	 and	 electron-donating	 groups	 were	comparable	in	efficiency.	
 
Scheme 1 DMI-based Suzuki Miyaura. Conditions: Pd(dppf)Cl2·CH2Cl2 
(4mol%), organoboron (1 equiv., 0.25 mmol), aryl/vinyl (pseudo)halide (1 
equiv., 0.25 mmol), K3PO4 (3 equiv., 0.75 mmol), DMI (1 mL), 1 h, 60°C. (a) X = 
OTf, (b) X = Cl, Pd(OAc)2 (4 mol%), SPhos (8 mol%), (c) Pd cat. (2 mol%, 0.005 
mmol), (d) 1.2 equiv. phenylboronic acid. We	 next	 focused	 on	 the	 optimization	 of	 the	 MH	 cross-coupling	(Table	2).	Initial	screening	of	the	iodobenzene	(4a)	system	 using	 Pd(PPh3)2Cl2	 catalyst	 revealed	 excellent	reactivity	at	80	°C	with	complete	conversion	 to	 the	desired	product	 6a	 in	 8	 hours	 (Table	 2,	 Entry	 1).	 We	 were	subsequently	 able	 to	 reduce	 reaction	 time	 (Entry	 2)	 but	found	 that	 lower	 temperatures	 resulted	 in	 a	 loss	 of	conversion	(Entry	3).	These	conditions	were	then	applied	to	the	bromobenzene	(4a’)	system	with	only	trace	amounts	of	product	 observed	 (Entry	 4).	 However,	 by	 increasing	 the	temperature,	 we	 found	 we	 were	 able	 to	 achieve	 high	conversion	over	24	hours	(Entry	6).	Upon	 moving	 to	 investigate	 the	 scope	 of	 the	 reaction,	 we	noticed	 that	 whilst	 coupling	 proceeded	 efficiently	 with	electron-rich	haloarenes,	the	coupling	of	4-iodonitrobenzene	
4f	using	Pd(PPh3)2Cl2	was	unsuccessful	(Entry	7).	However,	following	 a	 brief	 catalyst	 screen,	 Pd(dppf)Cl2	 was	 found	 to	deliver	 high	 reactivity	 and	 could	 facilitate	 the	 coupling	 in	good	isolated	yield	(Entry	9).		
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Table 2 Reaction optimisation of Mizoroki–Heck conditionsa 
 
 
Entry Reaction condit ions Conversion (%)b 
1 4a, Pd(PPh3)2Cl2, 80 °C, 8 h 100 
2 4a, Pd(PPh3)2Cl2, 80 °C, 1 h 100 
3 4a, Pd(PPh3)2Cl2, 60 °C, 1 h 12 
4 4a’, Pd(PPh3)2Cl2, 80 °C, 1 h <1 
5 4a’, Pd(PPh3)2Cl2, 80 °C, 24 h 81 
6 4a’, Pd(PPh3)2Cl2, 115 °C, 24 h 98
 
7 4f, Pd(PPh3)2Cl2, 80 °C, 1 h 0 
8 4f, Pd(PPh3)4, 80 °C, 1 h 0 
9 4f, Pd(dppf)Cl2, 80 °C, 1 h 85 
aIodobenzene (4a), bromobenzene (4a’) or 4-iodonitrobenzene (4f) (1 
equiv., 0.25 mmol), 5a (2 equiv., 0.5 mmol), Pd cat. (5 mol%, 0.013 mmol), 
Et3N (3 equiv., 0.75 mmol), DMI (1 mL, 0.25 M). 
bNMR conversion given as an 
average over 2 reactions.  	
 This	catalyst	system	was	effective	when	used	to	examine	the	substrate	scope	(Scheme	3).	Good	efficiency	was	observed	in	the	coupling	of	both	aryl	 iodides	(6c,	6e)	and	bromides	(6j,	
6h)	 and	 allowed	 for	 the	 coupling	 of	 electron-rich	 (6b,	6e)	and	 electron-deficient	 (6d,	 6g)	 arenes.	 Additionally,	 some	variance	 of	 activated	 alkene	 5	 could	 be	 tolerated	 with	 the	coupling	 of	 methyl	 vinyl	 ketone,	 phenyl	 vinyl	 ketone,	 and	
N,N-dimethylacrylamide	 undergoing	 successful	 coupling	 to	furnish	6i,	6k,	and	6m,	respectively.	Finally,	 we	 concluded	 our	 study	 on	 the	 use	 of	 DMI	 in	 Pd-catalysed	 bond	 forming	 reactions	 by	 investigating	 its	application	 within	 the	 Sonogashira	 reaction.	 Using	previously	 optimised	 conditions,31	 we	 found	 that	 the	coupling	 of	 4-fluoroiodobenzene	 with	 phenylacetylene,	 to	deliver	9a,	proceeded	smoothly	and	 in	high	yield,	based	on	this	 result	 further	 optimisation	 of	 the	 manifold	 was	 not	deemed	necessary.		Accordingly,	 these	 conditions	 were	 applied	 to	 a	 brief	substrate	 scope	 (Scheme	 4).	 A	 range	 of	 aryl	 iodides	 were	coupled	 under	 mild	 conditions	 in	 1	 hour,	 with	 multiple	substitution	patterns	tolerated	around	the	aryl	ring	(9b,	9d,	
9j).	 In	 addition,	 electron-deficient	 aryl	 bromides	 also	demonstrated	 compatibility,	 with	 5-bromo-2-nitropyridine	undergoing	conversion	to	9f	with	an	84%	isolated	yield.	Similarly,	 a	 variety	of	 groups	were	 tolerated	on	 the	alkyne,	with	 aryl	 (9h),	 vinyl	 (9l),	 and	 alkyl	 (9j)	 functionality	coupling	 successfully.	 In	 addition,	 alkynes	 substituted	with	modifiable	 groups	 such	 as	 BMIDA	 and	 TIPS,	 furnished	products	9g	and	9k	in	high	yields.	
 
Scheme 3 DMI-based Mizoroki-Heck. Conditions: Pd(dppf)Cl2·CH2Cl2 (5 
mol%, 0.013 mmol), aryl halide (1 equiv., 0.25 mmol), olefin (2 equiv., 0.5 
mmol), Et3N (3 equiv., 0.75 mmol), DMI (1 mL). (a) X = I, 1 h, 80 °C, (b) X = Br, 
24 h, 115°C, (c) K3PO4 (3 equiv., 0.75 mmol) used as base. 	
 
Scheme 4 DMI-based Sonogashira coupling. Conditions: Pd(PPh3)2Cl2 (2 
mol%), CuI (4 mol%), aryl halide (1 equiv., 0.25 mmol), alkyne (1.05 equiv., 
0.26 mmol), Et3N (3 equiv., 0.75 mmol), DMI (0.5 mL), 1 h, 25 °C. (a) 5-
Bromo-2-nitropyridine as coupling partner. With	regards	to	practicality,	DMI	has	a	high	boiling	point	and	issues	 may	 be	 expected	 in	 terms	 of	 its	 removal	 from	products.	 In	 our	 hands,	 we	 found	 that	 standard	 aqueous	washing	procedures	were	sufficient	 to	remove	 the	majority	of	DMI	 from	the	crude	products,	with	any	remaining	 traces	
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removed	during	purification	by	column	chromatography.	In	this	 context,	 DMI	 can	 be	 viewed	 as	 having	 similar	purification	 considerations	 as	 would	 be	 typically	 required	when	using	DMF	or	NMP.	In	 summary,	 we	 have	 shown	 the	 compatibility	 of	 the	 bio-based	 solvent	DMI	as	 an	alternative	 to	 solvents	of	 concern,	within	 Pd-catalyzed	 bond	 forming	 processes.	 Each	transformation	 (SM,	 MH,	 and	 Sonogashira),	 displays	excellent	 generality	 within	 the	 investigation	 of	 scope	 and	facilitated	the	preparation	of	a	range	of	small	molecules.	No	potential	 limitations	 (such	 as	 sensitivity	 towards	 reagents)	were	 identified	 throughout	 this	 study,	 and	 the	 non-mutagenic	 and	 non-toxic	 attributes,53	 in	 addition	 to	 the	renewable	 source	 of	 this	 solvent,	 make	 it	 an	 attractive	alternative	to	solvents	of	concern	such	as	DMF	and	THF.	
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4-Phenyltoluene	 (3a).	 Prepared	 according	 to	 the	 General	Procedure	using	Pd(dppf)Cl2·CH2Cl2	(8.2	mg,	0.01	mmol,	4	mol%),	bromotoluene	 1a	 (43	 mg,	 0.25	 mmol,	 1	 equiv.),	 phenylboronic	acid	 2a	 (30.5	 mg,	 0.25	 mmol,	 1	 equiv.),	 K3PO4	 (159	 mg,	 0.75	mmol,	3	equiv.),	DMI	(1	mL,	0.25	M),	and	H2O	(23	µL,	1.25	mmol,	5	 equiv.).	 After	 1	 h,	 the	 reaction	 mixture	 was	 subjected	 to	 the	purification	method	outlined	in	the	General	Procedure	(silica	gel,	0-5%	EtOAc	in	petroleum	ether)	to	afford	the	title	compound	as	a	white	 solid	 (42.9	mg,	quant.).	 1H	NMR	 (CDCl3,	 400	MHz):	 δ	7.62	(dd,	J	=	8.3,	1.2	Hz,	2H),	7.53	(d,	J	=	8.1	Hz,	2H),	7.46	(t,	J	=	7.6	Hz,	2H),	7.38	–	7.33	(m,	1H),	7.29	(d,	J	=	7.9	Hz,	2H),	2.43	(s,	3H).	13C	NMR	(CDCl3,	101	MHz):	δ	141.3,	138.5,	137.2,	129.6,	128.9,	127.1,	21.2.	(55) General	Procedure	for	Mizoroki-Heck	Coupling	in	DMI		To	 an	 oven	 dried	 5	 mL	 microwave	 vessel	 was	 added	Pd(dppf)Cl2·CH2Cl2	 (5	 mol%)	 and	 aryl	 halide	 (1	 equiv.).	 The	vessel	was	capped	and	purged	with	N2	before	addition	of	DMI	(1	
mL,	 0.25	 M),	 alkene	 coupling	 partner	 (2	 equiv.),	 and	 Et3N	 (3	equiv.).	The	reaction	mixture	was	heated	to	either	80	°C	(X=I)	or	115	 °C	 (X=Br)	 and	maintained	 at	 this	 temperature	with	 stirring	for	 1	 h	 (X=I)	 or	 24	 h	 (X=Br)	 before	 the	 vessel	was	 vented,	 and	decapped.	The	solution	was	then	diluted	with	EtOAc	(10	mL),	and	washed	 with	 water	 (2	 ×	 20	 mL)	 and	 brine	 (2	 ×	 20	 mL).	 The	organics	 were	 then	 passed	 through	 a	 hydrophobic	 frit	 and	concentrated	 under	 reduced	 pressure	 to	 give	 a	 residue,	 which	was	 purified	 by	 flash	 chromatography	 (silica	 gel)	 to	 afford	 the	product.		
Methyl	 cinnamate	 (6a).	 Prepared	 according	 to	 the	 General	Procedure	 using	 Pd(dppf)Cl2·CH2Cl2	 (10.2	 mg,	 0.013	 mmol,	 5	mol%),	 iodobenzene	 4a	 (28	 µL,	 0.25	 mmol,	 1	 equiv.),	 methyl	acrylate	5a	(45	µL,	0.5	mmol,	2	equiv.),	Et3N	(105	µL,	0.75	mmol,	3	equiv.),	DMI	(1	mL,	0.25	M).	After	1	h,	the	reaction	mixture	was	subjected	 to	 the	 purification	 method	 outlined	 in	 the	 General	Procedure	 (silica	 gel,	 0-5%	EtOAc	 in	 petroleum	 ether)	 to	 afford	the	 title	 compound	 as	 a	 white	 solid	 (40	 mg,	 99	 %).	 1H	 NMR	(CDCl3,	500	MHz):	δ	7.70	(d,	J	=	16.0	Hz,	1H),	7.53	(dd,	J	=	6.6,	2.8	Hz,	2H),	7.41	–	7.37	(m,	3H),	6.45	(d,	J	=	16.0	Hz,	1H),	3.81	(s,	3H).	13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 167.6,	 145.0,	 134.6,	 130.4,	 129.0,	128.2,	117.9,	51.8.	(56) General	Procedure	for	Sonogashira	Coupling	in	DMI		To	an	oven	dried	5	mL	microwave	vessel	was	added	Pd(PPh3)2Cl2	(2	 mol%),	 aryl	 halide	 (1	 equiv.),	 and	 alkyne	 coupling	 partner	(1.05	equiv.).	The	vessel	was	capped	and	purged	with	N2	before	addition	 of	 DMI	 (0.5	 mL,	 0.5	 M),	 and	 Et3N	 (1.1	 equiv.).	 The	reaction	 mixture	 was	 maintained	 at	 room	 temperature	 (25	 °C)	with	stirring	for	1	h	before	the	vessel	was	vented,	and	decapped.	The	 solution	was	 then	diluted	with	EtOAc	 (10	mL),	 and	washed	with	water	(2	×	20	mL)	and	brine	(2	×	20	mL).	The	organics	were	then	passed	 through	a	hydrophobic	 frit	 and	 concentrated	under	reduced	pressure	 to	 give	 a	 residue,	which	was	 purified	 by	 flash	chromatography	(silica	gel)	to	afford	the	product.		
1-Fluoro-4-(phenylethynyl)benzene	 (9a).	 Prepared	 according	to	the	General	Procedure	using	Pd(PPh3)2Cl2	(3.5	mg,	0.005	mmol,	2	mol%),	 4-fluoroiodobenzene	7a	 (29	µL,	 0.25	mmol,	 1	 equiv.),	phenylacetylene	8a	(29	µL,	0.26	mmol,	1.05	equiv.),	Et3N	(38	µL,	0.28	mmol,	1.1	equiv.),	DMI	(0.5	mL,	0.5	M).	After	1	h,	the	reaction	mixture	was	subjected	to	the	purification	method	outlined	in	the	General	Procedure	(silica	gel,	0-5%	EtOAc	in	petroleum	ether)	to	afford	the	title	compound	as	a	white	solid	(45	mg,	92	%).	1H	NMR	(CDCl3,	500	MHz):	δ	7.55	–	7.50	(m,	4H),	7.38	–	7.33	(m,	3H),	7.05	(t,	 J	 =	 8.7	 Hz,	 2H).	 13C	 NMR	 (CDCl3,	 126	MHz):	 δ	 162.7	 (d,	 1J	 =	249.6	Hz),	133.6	(d,	3J	=	8.2	Hz),	131.7,	128.5,	128.5,	123.3,	119.5	(d,	4J	=	3.4	Hz),	115.8	(d,	2J	=	22.4	Hz),	89.2,	88.4.	19F	NMR	(CDCl3,	471	MHz,)	δ	-110.98.	
	
